Obesity
Latest News
Does Semaglutide Reduce Inflammation?
Study finds an association between semaglutide and reduced inflammatory marker levels; implications are yet unknown.
Latest News
Pancreatic Gene Therapy: A ‘One-and-Done’ GLP-1 Treatment?
A single-dose pancreatic gene therapy may compare with GLP-1 effect, a mouse model study finds.
Latest News
Ghrelin Paradox: Unlocking New Avenues in Obesity Management
The hunger hormone’s role in appetite and weight gain may be an option for weight management as researchers look to therapeutic modulation.
Latest News
Tirzepatide Reduces Sleep Interruptions, Halting Almost Half of CPAP Use
Similar to other GLP-1s, tirzepatide, has been found to reduce sleep interruptions in patients with OSA and obesity.
Latest News
Metabolic Health Tied to Lower Prediabetes Risk
Compared with those in the metabolically healthy normal-weight group, the odds of prediabetes were at least two times higher in the metabolically...
Latest News
Bariatric Surgery Beats GLP-1 RAs in Reducing Mortality Risk
The reason may be greater weight loss with surgery.
From the Journals
Sugar Substitute Tied to Higher Risk for Heart Attack, Stroke
Xylitol is naturally found in small amounts in fruit and vegetables and has been used more as a sugar substitute over the past decade in processed...
Latest News
Is Cushing Syndrome More Common in the US Than We Think?
Providers get used to seeing patients with some features of cortisol excess and don’t think to screen.
Latest News
New Oral Weight Loss Drugs: Where Are We and What’s Next?
Drugmakers, including Aphaia Pharma, Novo Nordisk, and Aardvark Therapeutics, seek to make oral versions of injectable GLP-1s.
Latest News
Can Insulin Sensitivity Preserve Muscle During Weight Loss?
Identifying individuals with low insulin sensitivity prior to weight loss interventions could allow for personalized approaches to minimize lean...
Commentary
Is Semaglutide the ‘New Statin’? Not So Fast
Statins win in absolute cardiovascular disease risk reduction.